Breakout Ventures Secures $114 Million for AI-Driven Biology Fund III!

Breakout Ventures has closed its largest fund to date at $114 million, focusing on the integration of AI and biology. This funding will support science-driven companies from pre-seed to Series A stages. Managing partners Lindy Fishburne and Julia Moore aim to accelerate drug discovery and diagnostics. The firm’s total assets now exceed $230 million. Breakout backs innovative ventures like Noetik and Phantom Neuro, emphasizing a unique founder profile with a blend of scientific and engineering skills.